Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_assertion evidence source_evidence_literature NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_assertion SIO_000772 25193384 NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_assertion wasDerivedFrom befree-20150227 NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_assertion wasGeneratedBy ECO_0000203 NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.